Your browser doesn't support javascript.
loading
The effects of a peripherally selective alpha 2-adrenoceptor antagonist, MK-467, on the metabolic and cardiovascular response to exercise in healthy man.
Sciberras, D G; Reed, J W; Elliott, C; Blain, P G; Goldberg, M R.
Affiliation
  • Sciberras DG; Merck Sharp & Dohme Research Laboratories, Harlow, UK.
Br J Clin Pharmacol ; 37(1): 39-44, 1994 Jan.
Article in En | MEDLINE | ID: mdl-7908531
ABSTRACT
1. A double-blind, placebo controlled study has been conducted to investigate the consequences of i.v. treatment with MK-467, a peripherally selective alpha 2-adrenoceptor antagonist in exercising healthy male subjects. In particular, the effects on blood pressure, heart rate, circulating catecholamines (noradrenaline (NA) and adrenaline (A)), insulin, glucose and free fatty acids (FFA) were determined. 2. Exercise produced increases in catecholamines, blood pressure and heart rate. FFA increased at the start of the exercise but then declined as exercise progressed. 3. MK-467 significantly increased NA, in a dose-dependent manner, before and during exercise without altering A. Blood pressure and heart rate were not affected by drug treatment. 4. The insulin and FFA response to exercise was significantly enhanced by MK-467 although glucose was unaltered by drug. 5. It is concluded that both pre- and post-junctional peripheral alpha 2-receptors play an important role in the metabolic response to exercise in man.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quinolizines / Exercise / Catecholamines / Adrenergic alpha-Antagonists / Hemodynamics Type of study: Clinical_trials Limits: Adult / Humans / Male Language: En Journal: Br J Clin Pharmacol Year: 1994 Document type: Article Affiliation country: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quinolizines / Exercise / Catecholamines / Adrenergic alpha-Antagonists / Hemodynamics Type of study: Clinical_trials Limits: Adult / Humans / Male Language: En Journal: Br J Clin Pharmacol Year: 1994 Document type: Article Affiliation country: Reino Unido